Targeting the Trabecular Meshwork: Incorporating New Outflow Drugs Into Glaucoma Care

Targeting the Trabecular Meshwork: Incorporating New Outflow Drugs Into Glaucoma Care is organized by Evolve Medical Education (EME) LLC.

Release Date: Aug 24, 2020
Expiration Date: Aug 16, 2023

Activity Description:
Glaucoma is seeing a resurgence in innovative therapeutic developments. The recent approval of two drugs in novel classes for IOP reduction in eyes with ocular hypertension or open-angle glaucoma utilizes unique mechanisms of action not previously available with existing drug choices. This activity will provide education on the efficacy, safety, and mechanism of action of these two new drugs and how they compare to traditional glaucoma treatments.

Learning Objectives:
Upon completion of this activity, the participant should be able to:
• Describe the mechanisms of action of novel therapeutics and classes of drugs
• Compare the efficacy of novel therapeutics with traditional prostaglandins
• Understand and explain the likelihood of achieving target intraocular pressure with  monotherapy compared with combination regimens
• Restate the most common side effects of novel therapeutics
• Identify how to provide the best possible collaborative care when comanaging patients